BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8515074)

  • 1. IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth.
    Thomas SM; Garrity LF; Brandt CR; Schobert CS; Feng GS; Taylor MW; Carlin JM; Byrne GI
    J Immunol; 1993 Jun; 150(12):5529-34. PubMed ID: 8515074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-gamma-induced bacteriostasis but does not abrogate toxoplasmastasis.
    MacKenzie CR; Langen R; Takikawa O; Däubener W
    Eur J Immunol; 1999 Oct; 29(10):3254-61. PubMed ID: 10540337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha.
    Däubener W; Remscheid C; Nockemann S; Pilz K; Seghrouchni S; Mackenzie C; Hadding U
    Eur J Immunol; 1996 Feb; 26(2):487-92. PubMed ID: 8617321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of interferon-gamma-resistant phenotype by poly(I:C): possible involvement of ISGF2 (IRF1) in interferon-gamma-mediated induction of the IDO gene.
    Ozes ON; Taylor MW
    J Interferon Res; 1994 Feb; 14(1):25-32. PubMed ID: 8027591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.
    Taylor MW; Feng GS
    FASEB J; 1991 Aug; 5(11):2516-22. PubMed ID: 1907934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression.
    Yuan W; Collado-Hidalgo A; Yufit T; Taylor M; Varga J
    J Cell Physiol; 1998 Oct; 177(1):174-86. PubMed ID: 9731757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An indoleamine 2,3-dioxygenase-negative mutant is defective in stat1 DNA binding: differential response to IFN-gamma and IFN-alpha.
    Sotero-Esteva WD; Wolfe D; Ferris M; Taylor MW
    J Interferon Cytokine Res; 2000 Jul; 20(7):623-32. PubMed ID: 10926204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of transcription factors regulating induction of indoleamine 2,3-dioxygenase by IFN-gamma.
    Du MX; Sotero-Esteva WD; Taylor MW
    J Interferon Cytokine Res; 2000 Feb; 20(2):133-42. PubMed ID: 10714548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase.
    Däubener W; Spors B; Hucke C; Adam R; Stins M; Kim KS; Schroten H
    Infect Immun; 2001 Oct; 69(10):6527-31. PubMed ID: 11553600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IDO activation in anti-microbial defense in human native astrocytes.
    Oberdörfer C; Adams O; MacKenzie CR; De Groot CJ; Däubener W
    Adv Exp Med Biol; 2003; 527():15-26. PubMed ID: 15206712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-gamma in vivo.
    Burke F; Knowles RG; East N; Balkwill FR
    Int J Cancer; 1995 Jan; 60(1):115-22. PubMed ID: 7814143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells.
    Malone DG; Dolan PW; Brown RR; Kalayoglu MV; Arend RA; Byrne GI; Ozaki Y
    J Rheumatol; 1994 Jun; 21(6):1011-9. PubMed ID: 7523670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells.
    Dai W; Pan H; Kwok O; Dubey JP
    J Interferon Res; 1994 Dec; 14(6):313-7. PubMed ID: 7897249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha.
    Dai W; Gupta SL
    J Biol Chem; 1990 Nov; 265(32):19871-7. PubMed ID: 2174056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
    Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
    J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of antimicrobial effects by glucocorticoids.
    Türck J; Oberdörfer C; Vogel T; Mackenzie CR; Däubener W
    Med Microbiol Immunol; 2005 Jan; 194(1-2):47-53. PubMed ID: 14624357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-sensitive polymer-conjugated IFN-gamma induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG).
    Sarkhosh K; Tredget EE; Uludag H; Kilani RT; Karami A; Li Y; Iwashina T; Ghahary A
    J Cell Physiol; 2004 Oct; 201(1):146-54. PubMed ID: 15281097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced antichlamydial indoleamine dioxygenase activity independently.
    Currier AR; Ziegler MH; Riley MM; Babcock TA; Telbis VP; Carlin JM
    J Interferon Cytokine Res; 2000 Apr; 20(4):369-76. PubMed ID: 10805371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection.
    Pfaff AW; Mousli M; Sénégas A; Marcellin L; Takikawa O; Klein JP; Candolfi E
    Int J Parasitol; 2008 Feb; 38(2):249-58. PubMed ID: 17822706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism.
    Däubener W; MacKenzie CR
    Adv Exp Med Biol; 1999; 467():517-24. PubMed ID: 10721095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.